Nexus Surgical and Medicare Ltd

NEXUSSURGL Share Price

BSE

₹17.814.35% (-0.81)

Health Care

Pharmaceuticals

Smallcap

With a market cap of ₹9 cr, stock is ranked 4,879

High Risk

Stock is 6.38x as volatile as Nifty

NEXUSSURGL Stock Scorecard

Performance

Avg

Price return has been average, nothing exciting

Valuation

High

Seems to be overvalued vs the market average

Growth

Avg

Financials growth has been moderate for a few years

Profitability

High

Showing good signs of profitability & efficiency

Entry point

Avg

The stock is not in the overbought zone

Red flags

Low

No red flag found

How to use scorecard? Learn more

Health Care

Pharmaceuticals

Smallcap

With a market cap of ₹9 cr, stock is ranked 4,879

High Risk

Stock is 6.38x as volatile as Nifty

NEXUSSURGL Performance & Key Metrics

No LabelNo Label	PB RatioPB Ratio	Dividend YieldDiv. Yield
15.98	9.19	—

Sector PESector PE	Sector PBSector PB	Sector Div YldSctr Div Yld
36.71	5.79	0.58%

NEXUSSURGL Analyst Ratings & Forecast

—

Analyst Ratings data is currently unavailable for this stock

Price Upside

Earnings Growth

Rev. Growth

NEXUSSURGL Company Profile

Nexus Surgical and Medicare Limited is an India-based company engaged in the trading of surgical and pharmaceutical products. It imports and markets a range of medical supplies, including disposable syringes and sterilization pouches.

NEXUSSURGL Similar Stocks (Peers)

Compare with peers Compare with peers

NEXUSSURGL Similar Stocks (Peers)

Compare with peers Compare with peers

Sun Pharmaceutical Industries Ltd

SUNPHARMA

PE Ratio

38.47

1Y Return

10.56%

Buy Reco %

94.29

Torrent Pharmaceuticals Ltd

TORNTPHARM

PE Ratio

77.37

1Y Return

47.65%

Buy Reco %

81.48

Cipla Ltd

CIPLA

PE Ratio

20.71

1Y Return

3.97%

Buy Reco %

54.84

Dr Reddy's Laboratories Ltd

DRREDDY

PE Ratio

19.06

1Y Return

15.61%

Buy Reco %

48.39

Lupin Ltd

LUPIN

PE Ratio

32.19

1Y Return

18.34%

Buy Reco %

72.22

Compare with Peers

NEXUSSURGL Forecast

NEXUSSURGL Forecasts

NEXUSSURGL

Income

Balance Sheet

Cash Flow

Financial Year		FY 2017		FY 2018		FY 2019		FY 2020		FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	TTM
Total Revenue	0.30	1.04	2.22	1.73	3.75	2.42	1.56	3.50	5.73	7.33
Raw Materials	0.37	0.89	2.09	0.78	1.02	0.43	0.10	0.93	1.90	6.52
Power & Fuel Cost	0.00	0.01	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Employee Cost	0.08	0.22	0.09	0.15	0.32	0.22	0.25	0.24	0.41
Selling & Administrative Expenses	0.11	0.11	0.08	0.69	2.24	1.77	0.60	2.17	2.16
Operating & Other expenses	-0.07	0.13	0.05	5.39	-0.01	-0.39	0.38	-0.13	0.58
EBITDA	-0.19	-0.32	-0.09	-5.28	0.18	0.39	0.23	0.29	0.68	0.81
Depreciation/Amortization	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
PBIT	-0.19	-0.32	-0.09	-5.28	0.18	0.39	0.23	0.29	0.68	0.81
Interest & Other Items	0.01	0.00	0.00	0.00	0.00	0.00	0.00	0.01	0.01	0.00
PBT	-0.20	-0.32	-0.09	-5.28	0.18	0.39	0.23	0.28	0.67	0.81
Taxes & Other Items	0.00	0.01	0.00	0.02	0.01	0.10	0.06	0.08	0.17	0.20
Net Income	-0.20	-0.33	-0.09	-5.30	0.17	0.29	0.17	0.20	0.50	0.61
EPS	-0.37	-0.60	-0.16	-9.69	0.31	0.53	0.31	0.37	0.91	1.11
DPS	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Payout ratio	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00

NEXUSSURGL Income Statement

Quarter		sep 2023		dec 2023		mar 2024		jun 2024		sep 2024	dec 2024	mar 2025	jun 2025	sep 2025	dec 2025
Total Revenue	0.39	1.45	0.59	1.76	0.99	1.48	1.49	1.73	1.17	2.94
Operating & Other expenses	0.28	1.39	0.51	1.64	0.72	1.33	1.37	1.52	0.93	2.70
EBITDA	0.11	0.06	0.08	0.12	0.27	0.15	0.12	0.21	0.24	0.24
Depreciation/Amortization	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
PBIT	0.11	0.06	0.08	0.12	0.27	0.15	0.12	0.21	0.24	0.24
Interest & Other Items	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
PBT	0.11	0.06	0.08	0.12	0.27	0.15	0.12	0.21	0.24	0.24
Taxes & Other Items	0.03	0.02	0.02	0.03	0.07	0.04	0.03	0.05	0.06	0.06
Net Income	0.08	0.04	0.06	0.09	0.20	0.11	0.09	0.16	0.18	0.18
EPS	0.15	0.09	0.11	0.16	0.38	0.21	0.16	0.28	0.32	0.31

Financial Year		FY 2016		FY 2017		FY 2018		FY 2019		FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025
Cash from Operating Activities	-0.03	-0.17	-0.07	0.02	0.24	0.20	-0.11	0.55	-0.41	0.10
Cash from Investing Activities	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-0.01	0.00	-0.01
Cash from Financing Activities	0.09	0.20	-0.04	0.01	-0.26	0.00	0.00	0.00	0.00	0.00
Net Change in Cash	+0.06	+0.03	-0.11	+0.03	-0.02	+0.20	-0.11	+0.54	-0.41	+0.09
Changes in Working Capital	-0.12	+0.03	+0.25	+0.12	+0.17	+0.03	-0.51	+0.32	-0.71	-0.58
Capital Expenditures	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.01	0.00	0.01
Free Cash Flow	-0.03	-0.17	-0.07	0.02	0.24	0.20	-0.11	0.54	-0.41	0.09

NEXUSSURGL Company Updates

FY 2025FY 2025

Annual report

PDF

FY 2024FY 2024

Annual report

PDF

FY 2023FY 2023

Annual report

PDF

FY 2022FY 2022

Annual report

PDF

FY 2021FY 2021

Annual report

PDF

FY 2020FY 2020

Annual report

PDF

FY 2019FY 2019

Annual report

PDF

FY 2018FY 2018

Annual report

PDF

FY 2017FY 2017

Annual report

PDF

FY 2016FY 2016

Annual report

PDF

NEXUSSURGL Stock Peers

NEXUSSURGL Past Performance & Peer Comparison

Comparing 3 stocks from
Health CarePharmaceuticals

Valuation

Technical

Forecast

Compare valuation on Screener

Stock	PE RatioPE Ratio	PB RatioPB Ratio	Div. YieldDividend Yield
Nexus Surgical and Medicare Ltd	19.49	9.19	—
Sun Pharmaceutical Industries Ltd	38.47	5.80	0.91%
Torrent Pharmaceuticals Ltd	77.37	19.48	0.73%
Cipla Ltd	20.71	3.49	1.18%

NEXUSSURGL Stock Price Comparison

Compare NEXUSSURGL with any stock or ETF

NEXUSSURGL

NEXUSSURGL Holdings

NEXUSSURGL Shareholdings

NEXUSSURGL Promoter Holdings Trend

NEXUSSURGL Institutional Holdings Trend

NEXUSSURGL Shareholding Pattern

NEXUSSURGL Shareholding History

Foreign Institutions

NEXUSSURGL Insider Trades & Bulk Stock Deals

Hmm, looks like there hasn't been any net deal activity in the last 6 months

smallcases containing NEXUSSURGL stock

Looks like this stock is not in any smallcase yet.

NEXUSSURGL Events

NEXUSSURGL Dividend Trend

Dividends

Corp. Actions

Announcements

Legal Orders

NEXUSSURGL Dividend Trend

NEXUSSURGL Dividends

Hmm, looks like data is unavailable here. Please come back after some time

NEXUSSURGL Corp. Actions

Hmm, looks like data is unavailable here. Please come back after some time

No upcoming announcements are available

Result

Announced OnFeb 14, 2026

Nexus Surgical And Medicare Ltd - 538874

Nexus Surgical And Medicare Ltd - 538874 Download

Link

Download

Announced On

Feb 14, 2026

Board Meeting

Announced OnFeb 14, 2026

Nexus Surgical And Medicare Ltd - 538874

Nexus Surgical And Medicare Ltd - 538874 Download

Link

Download

Announced On

Feb 14, 2026

Board Meeting

Announced OnFeb 7, 2026

Nexus Surgical And Medicare Ltd - 538874

Nexus Surgical And Medicare Ltd - 538874 Download

Link

Download

Announced On

Feb 7, 2026

Company Update

Announced OnJan 5, 2026

Nexus Surgical And Medicare Ltd - 538874

Nexus Surgical And Medicare Ltd - 538874 Download

Link

Download

Announced On

Jan 5, 2026

Company Update

Announced OnJan 3, 2026

Nexus Surgical And Medicare Ltd - 538874

Nexus Surgical And Medicare Ltd - 538874 Download

Link

Download

Announced On

Jan 3, 2026

NEXUSSURGL Legal Orders

Hmm, looks like data is unavailable here. Please come back after some time

NEXUSSURGL Stock News & Opinions

Earnings

Nexus Surgical and Medicare standalone net profit rises 54.55% in the December 2025 quarter

Net profit of Nexus Surgical and Medicare rose 54.55% to Rs 0.17 crore in the quarter ended December 2025 as against Rs 0.11 crore during the previous quarter ended December 2024. Sales rose 97.97% to Rs 2.93 crore in the quarter ended December 2025 as against Rs 1.48 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales2.931.48 98 OPM %7.5110.14 - PBDT0.230.15 53 PBT0.230.15 53 NP0.170.11 55 Powered by Capital Market - Live

2 weeks agoCapital Market - Live

Corporate

Nexus Surgical & Medicare to announce Quarterly Result

Nexus Surgical & Medicare will hold a meeting of the Board of Directors of the Company on 14 February 2026.Powered by Capital Market - Live

3 weeks agoCapital Market - Live

Earnings

Nexus Surgical and Medicare standalone net profit declines 19.05% in the September 2025 quarter

Net profit of Nexus Surgical and Medicare declined 19.05% to Rs 0.17 crore in the quarter ended September 2025 as against Rs 0.21 crore during the previous quarter ended September 2024. Sales rose 18.18% to Rs 1.17 crore in the quarter ended September 2025 as against Rs 0.99 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales1.170.99 18 OPM %19.6628.28 - PBDT0.230.28 -18 PBT0.230.28 -18 NP0.170.21 -19 Powered by Capital Market - Live

3 months agoCapital Market - Live

Corporate

Nexus Surgical & Medicare to discuss results

Nexus Surgical & Medicare will hold a meeting of the Board of Directors of the Company on 14 November 2025.Powered by Capital Market - Live

3 months agoCapital Market - Live

Corporate

Nexus Surgical & Medicare AGM scheduled

Nexus Surgical & Medicare announced that the 34th Annual General Meeting(AGM) of the company will be held on 26 September 2025.Powered by Capital Market - Live

5 months agoCapital Market - Live

Corporate

Nexus Surgical & Medicare schedules board meeting

Nexus Surgical & Medicare will hold a meeting of the Board of Directors of the Company on 29 August 2025.Powered by Capital Market - Live

6 months agoCapital Market - Live

Earnings

Nexus Surgical and Medicare standalone net profit rises 66.67% in the June 2025 quarter

Net profit of Nexus Surgical and Medicare rose 66.67% to Rs 0.15 crore in the quarter ended June 2025 as against Rs 0.09 crore during the previous quarter ended June 2024. Sales declined 1.70% to Rs 1.73 crore in the quarter ended June 2025 as against Rs 1.76 crore during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var. Sales1.731.76 -2 OPM %11.566.82 - PBDT0.200.12 67 PBT0.200.12 67 NP0.150.09 67 Powered by Capital Market - Live

6 months agoCapital Market - Live

Corporate

Nexus Surgical & Medicare to discuss results

Nexus Surgical & Medicare will hold a meeting of the Board of Directors of the Company on 14 August 2025.Powered by Capital Market - Live

6 months agoCapital Market - Live

Earnings

Nexus Surgical and Medicare standalone net profit rises 50.00% in the March 2025 quarter

Net profit of Nexus Surgical and Medicare rose 50.00% to Rs 0.09 crore in the quarter ended March 2025 as against Rs 0.06 crore during the previous quarter ended March 2024. Sales rose 146.67% to Rs 1.48 crore in the quarter ended March 2025 as against Rs 0.60 crore during the previous quarter ended March 2024. For the full year,net profit rose 138.10% to Rs 0.50 crore in the year ended March 2025 as against Rs 0.21 crore during the previous year ended March 2024. Sales rose 64.84% to Rs 5.72 crore in the year ended March 2025 as against Rs 3.47 crore during the previous year ended March 2024. ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var. Sales1.480.60 147 5.723.47 65 OPM %7.4313.33 -11.547.49 - PBDT0.120.08 50 0.670.29 131 PBT0.120.08 50 0.670.29 131 NP0.090.06 50 0.500.21 138 Powered by Capital Market - Live

9 months agoCapital Market - Live

Corporate

Nexus Surgical & Medicare to discuss results

Nexus Surgical & Medicare will hold a meeting of the Board of Directors of the Company on 30 May 2025.Powered by Capital Market - Live

9 months agoCapital Market - Live

Frequently asked questions

What is the share price of Nexus Surgical and Medicare Ltd (NEXUSSURGL) today?
The share price of NEXUSSURGL as on 2nd March 2026 is ₹17.81. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.
What is the return on Nexus Surgical and Medicare Ltd (NEXUSSURGL) share?
The past returns of Nexus Surgical and Medicare Ltd (NEXUSSURGL) share are
- Past 1 week: -6.21%
- Past 1 month: 4.70%
- Past 3 months: 18.50%
- Past 6 months: -1.06%
- Past 1 year: 16.94%
- Past 3 years: 71.91%
- Past 5 years: 413.26%
What are the peers or stocks similar to Nexus Surgical and Medicare Ltd (NEXUSSURGL)?
The peers or stocks similar to Nexus Surgical and Medicare Ltd (NEXUSSURGL) include:
What is the market cap of Nexus Surgical and Medicare Ltd (NEXUSSURGL) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Nexus Surgical and Medicare Ltd (NEXUSSURGL) is ₹9.75 Cr as of 2nd March 2026.
What is the 52 week high and low of Nexus Surgical and Medicare Ltd (NEXUSSURGL) share?
The 52-week high of Nexus Surgical and Medicare Ltd (NEXUSSURGL) is ₹22 and the 52-week low is ₹13.26.
What is the PE and PB ratio of Nexus Surgical and Medicare Ltd (NEXUSSURGL) stock?
The P/E (price-to-earnings) ratio of Nexus Surgical and Medicare Ltd (NEXUSSURGL) is 19.49. The P/B (price-to-book) ratio is 9.19.
Which sector does Nexus Surgical and Medicare Ltd (NEXUSSURGL) belong to?
Nexus Surgical and Medicare Ltd (NEXUSSURGL) belongs to the Health Care sector & Pharmaceuticals sub-sector.
How to buy Nexus Surgical and Medicare Ltd (NEXUSSURGL) shares?
You can directly buy Nexus Surgical and Medicare Ltd (NEXUSSURGL) shares on Tickertape. Simply sign up, connect your demat account and place your order.

Stock	VolatilityVolatility	RSI–14DRSI – 14D	Price Mom RankPrice Momentum Rank
Nexus Surgical and Medicare Ltd	76.41%	52.49	Pro
Sun Pharmaceutical Industries Ltd	20.13%	61.18
Torrent Pharmaceuticals Ltd	20.99%	73.82
Cipla Ltd	20.38%	52.88

Nexus Surgical and Medicare Ltd

NEXUSSURGL Share Price

NEXUSSURGL Stock Scorecard

NEXUSSURGL Performance & Key Metrics

NEXUSSURGL Performance & Key Metrics

NEXUSSURGL Analyst Ratings & Forecast

Price Upside

Earnings Growth

Rev. Growth

NEXUSSURGL Company Profile

NEXUSSURGL Similar Stocks (Peers)

NEXUSSURGL Similar Stocks (Peers)

NEXUSSURGL Forecast

NEXUSSURGL Forecasts

NEXUSSURGL